Analysis of gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex

Journal of Experimental Medicine

Volumn 187, Issue 9, 1998, Pages 1373-1381

  Kuroda, Marcelo J ^a   Schmitz, Jörn E ^a   Barouch, Dan H ^a   Craiu, Abie ^a   Allen, Todd M ^b,c   Sette, Alessandro ^d   Watkins, David I ^b,c   Forman, Meryl A ^e   Letvin, Norman L ^a,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Eppimune   (United States)

^e BECKMAN COULTER INC   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; LYMPHOCYTE SUBPOPULATION; MACACA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SUPPRESSOR CELL; VIRUS INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES; FLOW CYTOMETRY; GENE PRODUCTS, GAG; HISTOCOMPATIBILITY ANTIGENS CLASS I; MACACA MULATTA; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032482190     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.9.1373     Document Type: Article

References (33)

1. Altman, J.D., P.A.M. Moss, P.J.K. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:94-96.
2. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowski, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
3. Reimann, K.A., K. Tenner-Racz, P. Racz, D.C. Montefiori, Y. Yasutomi, W. Lin, B.J. Ransil, and N.L. Letvin. 1994. Immunopathogenic events in the acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-2370.
4. Rinaldo, C., X.L. Huang, Z.F. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
5. Tsubota, H., C.I. Lord, D.I. Watkins, C. Morimoto, and N.L. Letvin. 1989. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. Exp. Med. 169:1421-1434.
6. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 234:1563-1566.
7. Miller, M.D., H. Yamamoto, A.H. Hughes, D.I. Watkins, and N.L. Letvin. 1991. Definition of an epitope and MHC class I molecule recognized by Gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J. Immunol. 147:320-329.
8. + cytotoxic T lymphocytes. J. Exp. Med. 176:1739-1744.
9. Yasutomi, Y., S. Koenig, S.S. Haun, C.K. Stover, R.K. Jackson, P. Conard, A.J. Conley, E.A. Emini, T.R. Fuerst, and N.L. Letvin. 1993. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 150:3101-3107.
10. + cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 151:5096-5105.
11. + cytotoxic T lymphocytes. Science. 252:440-443.
12. Allen, T.M., J. Sidney, M.-F. del Guercio, R.L. Glickman, G.L. Lensmeyer, D.A. Wiebe, R. DeMars, C.D. Pauza, R.P. Johnson, A. Sette, and D.I. Watkins. 1998. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from SIV. J. Immunol. In press.
13. Shatz, P.J. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology. 11:1138-1143.
14. Garboczi, D.N., D.T. Hung, and D.C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA. 89:3429-3433.
15. Watkins, D.I., M. Kannagi, M.S. Stone, and N.L. Letvin. 1988. Major histocompatibility complex class I molecule of nonhuman primates. Eur. J. Immunol. 18:1425-1432.
16. Yamamoto, H., M.D. Miller, H. Tsubota, D.I. Watkins, G.P. Mazzara, V. Stallard, D.L. Panicali, A. Aldovini, R.A. Young, and N.L. Letvin. 1990. Studies of cloned simian immunodeficiency virus-specific T lymphocytes: gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity. J. Immunol. 144:3385-3391.
17. Fazekas de St. Groth, S. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods. 49:R11-R23.
18. Baume, D.M., M.A. Caligiuri, T.J. Mauley, J.F. Daley, and J. Ritz. 1990. Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells. Cell. Immunol. 131:352-365.
19. Moebius, U., G. Kober, A.L. Griscelli, T. Hercend, and S.C. Meuer. 1991. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur. J. Immunol. 21:1793-1800.
20. Norment, A.M., and D.R. Littman. 1988. A second subunit of CD8 is expressed in human T cells. EMBO (Eur. Mol. Biol. Organ.) J. 7:3433-3439.
21. Terry, L.A., J.P. DiSanto, T.N. Small, and N. Flomemberg. 1990. Differential expression and regulation of human CD8α and CD8β chains. Tissue Antigens. 35:82-91.
22. Alcover, A. 1995. CD8 cluster report. In Leucocyte Typing V, White Cell Differentiation Antigens. Vol. 1. S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Siverstein, T. Springer, T.F. Tedder, and R.F. Todd, editors. Oxford University Press, Oxford. 353-354.
23. Rocha, B., P. Vassalli, and D. Gui-Grand. 1992. The extrathymic T-cell development pathway. Immunol. Today. 13:449-454.
24. Gotch, F.M., D.F. Nixon, N. Alp, A.J. McMichael, and L.K. Borysiewicz. 1990. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immunol. 2:707-712.
25. Koup, R.A., C.A. Pikora, K. Luzuriaga, D.B. Brettler, E.S. Day, G.P. Mazzara, and J.L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174:1593-1600.
26. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
27. Moss, P.A.H., S.L. Rowland-Jones, P.M. Frodsham, S. McAdam, P. Giangrande, A.J. McMichael, and J.I. Bell. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA. 92:5773-5777.
28. + cytotoxic T cells express CD38 and HLA-DR antigens. J. Immunol. 150:3070-3079.
29. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxiciry. Proc. Natl. Acad. Sci. USA. 87:4818-4822.
30. +CD28 lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J. Virol. 70:2022-2026.
31. + cell counts: correlations with various parameters of disease progression. AIDS. Res. Hum. Retroviruses. 12:497-506.
32. Couedel-Courteille, A., R. Le Grand, M. Tulliez, J.-G. Guillet, and A. Venet. 1997. Direct ex vivo simian immunodeficiency virus (SIV)-specific cytotoxic activity detected from small intestine intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection. J. Virol. 71:1052-1057.
33. Musey, L., J. Hughes, T. Schackter, T. Shea, L. Corey, and M.J. McElrath. 1997. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1306-1308.